n Obstetrics and Gynaecology Forum - Cost implications of the use of magnesium sulphate for the prevention of convulsions in severe pre-eclampsia : original article
|Article Title||Cost implications of the use of magnesium sulphate for the prevention of convulsions in severe pre-eclampsia : original article|
|© Publisher:||In House Publications|
|Journal||Obstetrics and Gynaecology Forum|
|Author||O. Owalabi and J. Moodley|
|Publication Date||Aug 2005|
|Pages||9 - 12|
<I>Objective:</I> To assess the direct financial costs of using MgS0<sub>4</sub> for the prevention of convulsions in the management of severe pre-eclampsia. <br><I>Method:</I> A prospective costing study using resource data obtained from hospital records. Unit costs per patient were calculated. The costs to health provider only, of using or not using MgS0<sub>4</sub> are reported. <br><I>Setting:</I> Department of Obstetrics and Gynaecology of King Edward VIII Hospital, Durban, South Africa. 196 patients records were analysed and reviewed between 1 July and 31 December 2003. <br><I>Results:</I> The average unit cost per day for patients on MgS0<sub>4</sub> was R1575.12 while that of those not on MgS0<sub>4</sub> was R1085.15. <br><I>Conclusion:</I> Use of MgS0<sub>4</sub> to treat the severe pre-eclamptic patient has cost implications but, a case for its use in patients with severe pre-eclampsia can be made.
Article metrics loading...